Infectious Diseases (except HIV/AIDS)
-
The time to offer treatments for COVID-19
This article has 37 authors:Reviewed by ScreenIT
-
Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction
This article has 10 authors:Reviewed by ScreenIT
-
Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study
This article has 84 authors:Reviewed by ScreenIT
-
Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study
This article has 20 authors:Reviewed by ScreenIT
-
Pooling for SARS-CoV-2 control in care institutions
This article has 9 authors:Reviewed by ScreenIT
-
Quantitative assessment of the risk of airborne transmission of SARS-CoV-2 infection: Prospective and retrospective applications
This article has 3 authors:Reviewed by ScreenIT
-
COVID-19: Why SOLIDARITY and DisCoVeRy trials may fail to bring informative and timely results
This article has 6 authors:Reviewed by ScreenIT
-
Mathematical Modeling and Analysis of COVID-19 pandemic in Nigeria
This article has 4 authors:Reviewed by ScreenIT
-
Antibody Profiling of COVID-19 Patients in an Urban Low-Incidence Region in Northern Germany
This article has 9 authors:Reviewed by ScreenIT
-
CIGB-258 immunomodulatory peptide: a novel promising treatment for critical and severe COVID-19 patients
This article has 16 authors:Reviewed by ScreenIT